{"success":true,"data":{"pressRelease":{"id":"139990","rtpr_id":"nGNE8bczZK-20260910","ticker":"ALMIB","exchange":"Euronext Paris","all_tickers":["ALMIB"],"title":"Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers","author":"Globe Newswire","published_at":"2026-09-10T09:34:05.310Z","article_body":"Basel, Switzerland and Chassieu, France, Sept. 10, 2026 (GLOBE NEWSWIRE) --\n* The exclusive agreement will span the cereals market across the European\nUnion, the United Kingdom, Ukraine and Switzerland, with first market launches\nfrom 2028/29; \n\n\n* This new-generation biocontrol fungicide, developed from Amoéba's solution,\nis designed to control septoria tritici blotch and yellow rust, two major\nfungal diseases affecting wheat, and other cereal diseases while helping to\nlimit the development of resistance, at a time when the number of available\nconventional treatment options is declining.\nSyngenta Crop Protection AG and Amoéba today announce an exclusive supply and\ndistribution agreement for a next-generation biocontrol fungicide (formulation\nAXP20), based on the lysate of the amoeba Willaertia magna C2c Maky (EU\n2025/1177). The agreement converts the companies' November 2025 Memorandum of\nUnderstanding (MoU) into a binding, long-term commercial and development\npartnership, with the product to be commercialized under a Syngenta trademark\nonce registered.\n\nThe deal arrives at a pivotal moment as European cereal growers face a\nshrinking crop protection toolbox amid tightening regulation and mounting\npathogen resistance.\n\nFirst market registrations are expected for Q3 2028. First sales in core EU\nmarkets are expected by the end of 2028 for use by farmers in spring 2029 in\nwheat, spelt, and triticale (spring and winter).\n\nA critical tool against Europe's costliest cereal threats\n\nUnder this agreement, Syngenta will be the exclusive distributor of the\nbiofungicide for all cereals (except corn) across the EU-27, the United\nKingdom, Ukraine, and Switzerland, targeting firstly the two most economically\ndamaging fungal diseases in European cereals: septoria tritici blotch\n(Zymoseptoria tritici) and yellow rust (Puccinia striiformis).\n\nThe scale is significant. Together, these diseases affect an estimated 9 to 12\nmillion hectares annually. In Germany alone, septoria drives yield losses of\n5% to 50%, costing farmers up to €1.5 billion every year, while yellow rust\ncan slash yields by 10% to 70% and cause total crop failure in susceptible\nvarieties, according to recognized industry and academic sources.\n\nMatthew Pickard, Syngenta's Head of Seedcare and Biologicals for Europe, said:\n\"With conventional crop protection facing mounting regulatory and resistance\nheadwinds, this next-generation biofungicide arrives at exactly the right\nmoment - a genuine breakthrough for our biocontrol portfolio and for every\ncereal farmer looking to protect their yields and strengthen the resilience of\ntheir farming system.\"\n\nA distinct mode of action for modern crop management\n\nA key differentiator of this technology lies in its unique biological origin.\nDerived from a single-celled amoeba, it works mainly by inhibiting the\ngermination of fungal spores. In field trials, it has shown strong efficacy\nagainst both septoria and yellow rust while activating the plant's own natural\ndefenses - a dual performance that makes it a natural fit for integrated crop\nmanagement and a valuable tool for resistance management.\n\nOwing to its multisite, multi-mechanism activity, the lysate of Willaertia\nmagna C2c Maky is classified by the Fungicide Resistance Action Committee\n(FRAC) under Group BM02—biologicals with multiple modes of action—with no\nknown resistance and a low to very low resistance risk.\n\nThis significant potential is backed at the highest level: the active\nsubstance received EU approval in 2025 following EFSA's assessment. In June\n2026, Amoéba secured its marketing authorization in France for AXPERA, a\nbiofungicide based on the same technology. This landmark approval clears the\npath for other Member States to finalize national authorizations in the coming\nmonths, accelerating the route to market. Furthermore, in October 2025,\nAmoéba was awarded the prestigious Bernard Blum Gold Medal as the most\npromising biocontrol solution of the year and its solution was recognised as\nthe innovative solution of the year by professionals in the SIVAL in January\n2026.\n\n\"Signing this binding agreement with Syngenta is a defining milestone for\nAmoéba. We are proud to partner with the cereals leader in Europe. Among many\nother biological solutions, Syngenta’s screening has selected AXP20 as the\nhighest performing biofungicide: our solution is the first next-generation\nbiofungicide able to control both yellow rust and septoria diseases in wheat.\nFor the most important market in Europe, Green for Agro was looking for the\nbest partner with recognized experience launching and marketing biofungicides\nwith cereal growers in Europe”, said Jean-Marc Petat, Managing Director of\nGreen for Agro, Amoéba's biosolutions subsidiary.\n\nBacked by one of biocontrol's most ambitious development programs\n\nThe partners are putting significant resources behind AXP20. In 2026 alone,\nSyngenta and Amoéba are jointly conducting more than 70 field trials, with\nboth companies committed to expanding this collaboration further – making it\none of the most extensive validation efforts in the biocontrol space.\n\nAXP20 ranks among the key products in Syngenta's biologicals portfolio.\nCapable of protecting more than 1 million hectares of cereals across its\nexpanding European footprint, it strengthens Syngenta's leadership in the\nbiofungicide market for cereals.  \n\nAgreement terms and route-to-market\n\nSyngenta holds exclusive distribution rights for all cereals (except corn)\nacross the EU-27, the United Kingdom, Ukraine, and Switzerland.\n\nBoth companies are now advancing joint regulatory and field-trial programs\nacross Europe, with first registrations targeted for Q3 2028 in core EU\nmarkets and around 2029 in the UK and Switzerland. Beyond wheat, the\npartnership already envisages extending the product into new crops and\ngeographies as its efficacy profile broadens, reinforcing its potential as a\nlong-term growth platform.\n\nEditor's note: The product trademark is pending regulatory approval and will\nbe confirmed ahead of first commercial launch. The product is referred to by\nits development code AXP20 in this release.\n\n Media Contacts                                                                                                                                                                                                                                                                                                                                                                                                                                                         Web Resources                                                     \n Syngenta Media Relations media@syngentagroup.com   Julien Fourmont Business Development, 3rd Party & Service Lead julien.fourmont@syngenta.com   Klaus Bassermann Product Manager Disease Control Biocontrol Europe klaus.bassermann@syngenta.com   Amoéba Media Relations Pierre Jacquemin-Guillaume Investor relations amoeba@actus.fr  Serena Boni Financial press relations sboni@actus.fr  Laëtitia Pinto Business and general public press relations             Pictures (https://www.syngentagroup.com/media/media-library/)     \n pinto@droitdevant.fr                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n\nAbout Syngenta\n\nSyngenta is a leading science-based agricultural technology (AgTech) company,\ncreating Breakthroughs for farmers, in every field™ to help meet the\ndemands of modern agriculture. Using cutting-edge innovation and guided by\nits Sustainability Goal\n(https://www.globenewswire.com/Tracker?data=9L5Klu-OE3M4j_kRfVQdBp03LA3GROwddkvxzc587hCbPnkosavWL7fSipwoYvcu4yO9ea2eYEHgKhLrUECehNSqBuSBrD7qE6S6Xd7lOOZrTjBVrdWDga32rym-kd-s) of\nhigher yields with lower impact, Syngenta helps farmers to grow resilient,\nhealthy crops that can feed a growing global population, while protecting and\nenhancing the planet. Syngenta employs more than 30,000 employees in over 90\ncountries and is part of Syngenta Group. It consists of two business units:\nSyngenta Crop Protection\n(https://www.globenewswire.com/Tracker?data=GHB0KL3OBMwGmcNpf3Wh_E8q06Ba-QLan6y3V6MD2bODAJ_GsLCVnXEtuHLF1K0v8W8NgywuQuRJzorB-Zwxeb74FAUO8flaOjk5Ymmu2iMbHGAOIR8ijUK8iKIo3SoNZsPSu9a5EylWO57hV_ktdg==),\nheadquartered in Switzerland, and Syngenta Seeds\n(https://www.globenewswire.com/Tracker?data=GHB0KL3OBMwGmcNpf3Wh_NwSojurOUAAvvW8R264EzgUSRpjMQDfD4zmhb5zQxxgl4abeBfCC2BE45I6JzeIuod1AQoEW2ajbp89URuY7vWGhN7pJ-0vxRLsuvFXLL1k), headquartered\nin the United States.\n\nTo find out more about how Syngenta creates breakthroughs for farmers around\nthe world, read our stories\n(https://www.globenewswire.com/Tracker?data=985VsD8BnEf0Ce6O_poVwCTRIOwUnW6cJibwDgyCIy9J_bBly-9ACC-WmwaPXikP6JdpfYEcIyuc0_3H8mk2hIb6OuC6MHYbdM4jYa5YSaY=) and\nfollow us on social media. \n\n\n\nData protection is important to us. You are receiving this publication on the\nlegal basis of Article 6 para 1 lit. f GDPR (“legitimate interest”).\nHowever, if you do not wish to receive further information about Syngenta,\njust send us a brief informal message\n(https://www.globenewswire.com/Tracker?data=e9h6U-YjvY0MzizaUJ3DLC3gU_3jvWd_mW0AawULHA0EfOPdVZUSpTbi9ChSyNq8gFTsKwAkpKGf43mSt7AJTAnhpnyA997IXpXixn8oeUJF3v4efg15rujW1DJGpNCS)\nand we will no longer process your details for this purpose. You can also find\nfurther details in our privacy statement. \n(https://www.globenewswire.com/Tracker?data=OD2S6IzKakwSx8oU0n-k1zcRWYhohxqLa19hAd4unDk9-_rYy7xBLUtGokBf6qf2yedPCRInZDe6VcgqxOYFOqNGoK3L8l4UHKYwh4P05vM=)\n\nAbout Amoéba\n\nFounded in 2010, Amoéba is a greentech company based in Chassieu (Lyon,\nFrance) whose ambition is to become a major player in the treatment of\nmicrobiological risk based on the patented use of amoebae in the plant\nprotection and cosmetics sectors.\n\nAmoéba is currently focusing on the global biocontrol market for plant\nprotection and the cosmetics market. As the marketing of plant protection\nproducts is subject to obtaining local regulatory approvals, the Company has\ntaken the necessary regulatory steps and submitted applications for approval\nin Europe and the United States. The active substance has already been\napproved in the United States in 2022 and received a positive and final report\nfrom the EFSA in Europe. The AXPERA product was granted marketing\nauthorisation in 2025 in the United States and in 2026 in France, ahead of\nother targeted European countries.\n\nAmoéba is listed on Euronext Growth (ALMIB). The company is a member of the\nBpifrance Excellence network and is eligible for the PEA-PME scheme.\n\nFor more information, visit www.amoeba-nature.com     \n\nSyngenta’s Cautionary Statement Regarding Forward-Looking Statements\n\nThis document may contain forward-looking statements, which can be identified\nby terminology such as “believe,” “anticipate,” “expect,”\n“intend,” “plan,” “will,” “may,” “should,” “estimate,”\n“predict,” “potential,” “continue” and similar expressions.\nForward-looking statements include statements concerning Syngenta’s future\nexpectations, plans, prospects, objectives, performance or events, including\nstatements attributed to individuals quoted in this document, whether or not\nthey use such terminology. Such statements are based on current expectations,\nassumptions, estimates and projections and are subject to known and unknown\nrisks, uncertainties and other factors that could cause actual results,\nperformance or achievements to differ materially from those expressed or\nimplied by them. They are not guarantees of future performance, and readers\nshould not place undue reliance on them. For Syngenta, such risks and\nuncertainties include, amongst others, risks relating to legal proceedings,\nregulatory approvals, new product development, increasing competition,\ncustomer credit risk, general economic and market conditions, refinancing\nrisk, interest rate fluctuations and access to capital markets, compliance and\nremediation, evolving environmental and sustainability regulations, changes in\nagricultural policies or subsidy regimes, intellectual property rights,\nimplementation of organizational changes, impairment of intangible assets,\nconsumer perceptions of genetically modified crops and organisms or crop\nprotection chemicals, climate change and extreme weather events, fluctuations\nin exchange rates and/or agricultural commodity prices, supply chain\ndisruptions, including risks arising from single-source supply arrangements,\ngeopolitical risks, trade restrictions, sanctions, and export controls,\nnatural disasters, and cybersecurity incidents, data breaches, and failures or\ndisruptions of information technology systems. Forward-looking statements\nspeak only as of the date of this document. Except as required by applicable\nlaw, Syngenta undertakes no obligation to update or revise any forward-looking\nstatement, whether as a result of new information, future events, changed\nassumptions or otherwise.\n\n©2026 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland.\n\nAttachment\n*     2026_09_08_Amoeba_Syngenta_vdef\n(https://ml.globenewswire.com/Resource/Download/1c97068c-9db3-4659-86f0-e2d276c90cc2)\n\nSyngenta Media Relations\nmedia@syngentagroup.com\n\nJulien Fourmont\nBusiness Development, 3rd Party & Service Lead\njulien.fourmont@syngenta.com\n\nKlaus Bassermann\nProduct Manager Disease Control Biocontrol Europe\nklaus.bassermann@syngenta.com\n\nAmoéba Media Relations\nPierre Jacquemin-Guillaume\nInvestor relations\namoeba@actus.fr\n\nSerena Boni\nFinancial press relations\nsboni@actus.fr\n\nLaëtitia Pinto\nBusiness and general public press relations\npinto@droitdevant.fr","article_body_html":"","raw_payload":{"data":{"id":"nGNE8bczZK-20260910","title":"Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers","author":"Globe Newswire","ticker":"ALMIB","created":"2026-09-10T09:34:05.310Z","tickers":["ALMIB"],"exchange":"Euronext Paris","article_body":"Basel, Switzerland and Chassieu, France, Sept. 10, 2026 (GLOBE NEWSWIRE) --\n* The exclusive agreement will span the cereals market across the European\nUnion, the United Kingdom, Ukraine and Switzerland, with first market launches\nfrom 2028/29; \n\n\n* This new-generation biocontrol fungicide, developed from Amoéba's solution,\nis designed to control septoria tritici blotch and yellow rust, two major\nfungal diseases affecting wheat, and other cereal diseases while helping to\nlimit the development of resistance, at a time when the number of available\nconventional treatment options is declining.\nSyngenta Crop Protection AG and Amoéba today announce an exclusive supply and\ndistribution agreement for a next-generation biocontrol fungicide (formulation\nAXP20), based on the lysate of the amoeba Willaertia magna C2c Maky (EU\n2025/1177). The agreement converts the companies' November 2025 Memorandum of\nUnderstanding (MoU) into a binding, long-term commercial and development\npartnership, with the product to be commercialized under a Syngenta trademark\nonce registered.\n\nThe deal arrives at a pivotal moment as European cereal growers face a\nshrinking crop protection toolbox amid tightening regulation and mounting\npathogen resistance.\n\nFirst market registrations are expected for Q3 2028. First sales in core EU\nmarkets are expected by the end of 2028 for use by farmers in spring 2029 in\nwheat, spelt, and triticale (spring and winter).\n\nA critical tool against Europe's costliest cereal threats\n\nUnder this agreement, Syngenta will be the exclusive distributor of the\nbiofungicide for all cereals (except corn) across the EU-27, the United\nKingdom, Ukraine, and Switzerland, targeting firstly the two most economically\ndamaging fungal diseases in European cereals: septoria tritici blotch\n(Zymoseptoria tritici) and yellow rust (Puccinia striiformis).\n\nThe scale is significant. Together, these diseases affect an estimated 9 to 12\nmillion hectares annually. In Germany alone, septoria drives yield losses of\n5% to 50%, costing farmers up to €1.5 billion every year, while yellow rust\ncan slash yields by 10% to 70% and cause total crop failure in susceptible\nvarieties, according to recognized industry and academic sources.\n\nMatthew Pickard, Syngenta's Head of Seedcare and Biologicals for Europe, said:\n\"With conventional crop protection facing mounting regulatory and resistance\nheadwinds, this next-generation biofungicide arrives at exactly the right\nmoment - a genuine breakthrough for our biocontrol portfolio and for every\ncereal farmer looking to protect their yields and strengthen the resilience of\ntheir farming system.\"\n\nA distinct mode of action for modern crop management\n\nA key differentiator of this technology lies in its unique biological origin.\nDerived from a single-celled amoeba, it works mainly by inhibiting the\ngermination of fungal spores. In field trials, it has shown strong efficacy\nagainst both septoria and yellow rust while activating the plant's own natural\ndefenses - a dual performance that makes it a natural fit for integrated crop\nmanagement and a valuable tool for resistance management.\n\nOwing to its multisite, multi-mechanism activity, the lysate of Willaertia\nmagna C2c Maky is classified by the Fungicide Resistance Action Committee\n(FRAC) under Group BM02—biologicals with multiple modes of action—with no\nknown resistance and a low to very low resistance risk.\n\nThis significant potential is backed at the highest level: the active\nsubstance received EU approval in 2025 following EFSA's assessment. In June\n2026, Amoéba secured its marketing authorization in France for AXPERA, a\nbiofungicide based on the same technology. This landmark approval clears the\npath for other Member States to finalize national authorizations in the coming\nmonths, accelerating the route to market. Furthermore, in October 2025,\nAmoéba was awarded the prestigious Bernard Blum Gold Medal as the most\npromising biocontrol solution of the year and its solution was recognised as\nthe innovative solution of the year by professionals in the SIVAL in January\n2026.\n\n\"Signing this binding agreement with Syngenta is a defining milestone for\nAmoéba. We are proud to partner with the cereals leader in Europe. Among many\nother biological solutions, Syngenta’s screening has selected AXP20 as the\nhighest performing biofungicide: our solution is the first next-generation\nbiofungicide able to control both yellow rust and septoria diseases in wheat.\nFor the most important market in Europe, Green for Agro was looking for the\nbest partner with recognized experience launching and marketing biofungicides\nwith cereal growers in Europe”, said Jean-Marc Petat, Managing Director of\nGreen for Agro, Amoéba's biosolutions subsidiary.\n\nBacked by one of biocontrol's most ambitious development programs\n\nThe partners are putting significant resources behind AXP20. In 2026 alone,\nSyngenta and Amoéba are jointly conducting more than 70 field trials, with\nboth companies committed to expanding this collaboration further – making it\none of the most extensive validation efforts in the biocontrol space.\n\nAXP20 ranks among the key products in Syngenta's biologicals portfolio.\nCapable of protecting more than 1 million hectares of cereals across its\nexpanding European footprint, it strengthens Syngenta's leadership in the\nbiofungicide market for cereals.  \n\nAgreement terms and route-to-market\n\nSyngenta holds exclusive distribution rights for all cereals (except corn)\nacross the EU-27, the United Kingdom, Ukraine, and Switzerland.\n\nBoth companies are now advancing joint regulatory and field-trial programs\nacross Europe, with first registrations targeted for Q3 2028 in core EU\nmarkets and around 2029 in the UK and Switzerland. Beyond wheat, the\npartnership already envisages extending the product into new crops and\ngeographies as its efficacy profile broadens, reinforcing its potential as a\nlong-term growth platform.\n\nEditor's note: The product trademark is pending regulatory approval and will\nbe confirmed ahead of first commercial launch. The product is referred to by\nits development code AXP20 in this release.\n\n Media Contacts                                                                                                                                                                                                                                                                                                                                                                                                                                                         Web Resources                                                     \n Syngenta Media Relations media@syngentagroup.com   Julien Fourmont Business Development, 3rd Party & Service Lead julien.fourmont@syngenta.com   Klaus Bassermann Product Manager Disease Control Biocontrol Europe klaus.bassermann@syngenta.com   Amoéba Media Relations Pierre Jacquemin-Guillaume Investor relations amoeba@actus.fr  Serena Boni Financial press relations sboni@actus.fr  Laëtitia Pinto Business and general public press relations             Pictures (https://www.syngentagroup.com/media/media-library/)     \n pinto@droitdevant.fr                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n\nAbout Syngenta\n\nSyngenta is a leading science-based agricultural technology (AgTech) company,\ncreating Breakthroughs for farmers, in every field™ to help meet the\ndemands of modern agriculture. Using cutting-edge innovation and guided by\nits Sustainability Goal\n(https://www.globenewswire.com/Tracker?data=9L5Klu-OE3M4j_kRfVQdBp03LA3GROwddkvxzc587hCbPnkosavWL7fSipwoYvcu4yO9ea2eYEHgKhLrUECehNSqBuSBrD7qE6S6Xd7lOOZrTjBVrdWDga32rym-kd-s) of\nhigher yields with lower impact, Syngenta helps farmers to grow resilient,\nhealthy crops that can feed a growing global population, while protecting and\nenhancing the planet. Syngenta employs more than 30,000 employees in over 90\ncountries and is part of Syngenta Group. It consists of two business units:\nSyngenta Crop Protection\n(https://www.globenewswire.com/Tracker?data=GHB0KL3OBMwGmcNpf3Wh_E8q06Ba-QLan6y3V6MD2bODAJ_GsLCVnXEtuHLF1K0v8W8NgywuQuRJzorB-Zwxeb74FAUO8flaOjk5Ymmu2iMbHGAOIR8ijUK8iKIo3SoNZsPSu9a5EylWO57hV_ktdg==),\nheadquartered in Switzerland, and Syngenta Seeds\n(https://www.globenewswire.com/Tracker?data=GHB0KL3OBMwGmcNpf3Wh_NwSojurOUAAvvW8R264EzgUSRpjMQDfD4zmhb5zQxxgl4abeBfCC2BE45I6JzeIuod1AQoEW2ajbp89URuY7vWGhN7pJ-0vxRLsuvFXLL1k), headquartered\nin the United States.\n\nTo find out more about how Syngenta creates breakthroughs for farmers around\nthe world, read our stories\n(https://www.globenewswire.com/Tracker?data=985VsD8BnEf0Ce6O_poVwCTRIOwUnW6cJibwDgyCIy9J_bBly-9ACC-WmwaPXikP6JdpfYEcIyuc0_3H8mk2hIb6OuC6MHYbdM4jYa5YSaY=) and\nfollow us on social media. \n\n\n\nData protection is important to us. You are receiving this publication on the\nlegal basis of Article 6 para 1 lit. f GDPR (“legitimate interest”).\nHowever, if you do not wish to receive further information about Syngenta,\njust send us a brief informal message\n(https://www.globenewswire.com/Tracker?data=e9h6U-YjvY0MzizaUJ3DLC3gU_3jvWd_mW0AawULHA0EfOPdVZUSpTbi9ChSyNq8gFTsKwAkpKGf43mSt7AJTAnhpnyA997IXpXixn8oeUJF3v4efg15rujW1DJGpNCS)\nand we will no longer process your details for this purpose. You can also find\nfurther details in our privacy statement. \n(https://www.globenewswire.com/Tracker?data=OD2S6IzKakwSx8oU0n-k1zcRWYhohxqLa19hAd4unDk9-_rYy7xBLUtGokBf6qf2yedPCRInZDe6VcgqxOYFOqNGoK3L8l4UHKYwh4P05vM=)\n\nAbout Amoéba\n\nFounded in 2010, Amoéba is a greentech company based in Chassieu (Lyon,\nFrance) whose ambition is to become a major player in the treatment of\nmicrobiological risk based on the patented use of amoebae in the plant\nprotection and cosmetics sectors.\n\nAmoéba is currently focusing on the global biocontrol market for plant\nprotection and the cosmetics market. As the marketing of plant protection\nproducts is subject to obtaining local regulatory approvals, the Company has\ntaken the necessary regulatory steps and submitted applications for approval\nin Europe and the United States. The active substance has already been\napproved in the United States in 2022 and received a positive and final report\nfrom the EFSA in Europe. The AXPERA product was granted marketing\nauthorisation in 2025 in the United States and in 2026 in France, ahead of\nother targeted European countries.\n\nAmoéba is listed on Euronext Growth (ALMIB). The company is a member of the\nBpifrance Excellence network and is eligible for the PEA-PME scheme.\n\nFor more information, visit www.amoeba-nature.com     \n\nSyngenta’s Cautionary Statement Regarding Forward-Looking Statements\n\nThis document may contain forward-looking statements, which can be identified\nby terminology such as “believe,” “anticipate,” “expect,”\n“intend,” “plan,” “will,” “may,” “should,” “estimate,”\n“predict,” “potential,” “continue” and similar expressions.\nForward-looking statements include statements concerning Syngenta’s future\nexpectations, plans, prospects, objectives, performance or events, including\nstatements attributed to individuals quoted in this document, whether or not\nthey use such terminology. Such statements are based on current expectations,\nassumptions, estimates and projections and are subject to known and unknown\nrisks, uncertainties and other factors that could cause actual results,\nperformance or achievements to differ materially from those expressed or\nimplied by them. They are not guarantees of future performance, and readers\nshould not place undue reliance on them. For Syngenta, such risks and\nuncertainties include, amongst others, risks relating to legal proceedings,\nregulatory approvals, new product development, increasing competition,\ncustomer credit risk, general economic and market conditions, refinancing\nrisk, interest rate fluctuations and access to capital markets, compliance and\nremediation, evolving environmental and sustainability regulations, changes in\nagricultural policies or subsidy regimes, intellectual property rights,\nimplementation of organizational changes, impairment of intangible assets,\nconsumer perceptions of genetically modified crops and organisms or crop\nprotection chemicals, climate change and extreme weather events, fluctuations\nin exchange rates and/or agricultural commodity prices, supply chain\ndisruptions, including risks arising from single-source supply arrangements,\ngeopolitical risks, trade restrictions, sanctions, and export controls,\nnatural disasters, and cybersecurity incidents, data breaches, and failures or\ndisruptions of information technology systems. Forward-looking statements\nspeak only as of the date of this document. Except as required by applicable\nlaw, Syngenta undertakes no obligation to update or revise any forward-looking\nstatement, whether as a result of new information, future events, changed\nassumptions or otherwise.\n\n©2026 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland.\n\nAttachment\n*     2026_09_08_Amoeba_Syngenta_vdef\n(https://ml.globenewswire.com/Resource/Download/1c97068c-9db3-4659-86f0-e2d276c90cc2)\n\nSyngenta Media Relations\nmedia@syngentagroup.com\n\nJulien Fourmont\nBusiness Development, 3rd Party & Service Lead\njulien.fourmont@syngenta.com\n\nKlaus Bassermann\nProduct Manager Disease Control Biocontrol Europe\nklaus.bassermann@syngenta.com\n\nAmoéba Media Relations\nPierre Jacquemin-Guillaume\nInvestor relations\namoeba@actus.fr\n\nSerena Boni\nFinancial press relations\nsboni@actus.fr\n\nLaëtitia Pinto\nBusiness and general public press relations\npinto@droitdevant.fr"},"type":"article","timestamp":"2026-09-10T09:34:05.428776746Z","server_sent_at_ms":1789032845428},"received_at":"2026-09-10T09:34:05.601Z","source_url":null},"analysis":{"id":"128826","press_release_id":"139990","analysis_json":{"industry":{"label":"Chemicals","sector":"Materials"},"redFlags":["No financial terms disclosed (no upfront payment, royalties, or deal value)","Revenue not expected until end-2028 — long cash-flow runway for a micro-cap","Product registrations and trademark still pending regulatory approval; national Member State authorizations not yet finalized","Full commercial dependence on a single exclusive distribution partner (Syngenta)"],"eventType":"partnership","narrative":"Amoéba and Syngenta Crop Protection have signed a binding exclusive supply and distribution agreement for the next-generation biocontrol fungicide AXP20, converting their November 2025 MoU into a long-term commercial and development partnership covering all cereals except corn across the EU-27, UK, Ukraine, and Switzerland.\n\nFirst registrations are targeted for Q3 2028 in core EU markets and around 2029 in the UK and Switzerland, with first sales expected by end of 2028 for farmer use in spring 2029 under a Syngenta trademark.\n\nThe product targets septoria tritici blotch and yellow rust — Europe's most economically damaging cereal diseases, affecting an estimated 9 to 12 million hectares annually — and the partners are running more than 70 joint field trials in 2026, with AXP20 capable of protecting more than 1 million hectares.\n\nAmoéba holds EU approval for the active substance (2025) and a June 2026 French marketing authorization for AXPERA; for the Euronext Growth-listed micro-cap this is a defining commercialization milestone, though no financial terms were disclosed and revenue remains nearly two years out.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"Syngenta converts MoU into binding exclusive European distribution deal for Amoéba's AXP20 biofungicide — major commercial validation, but cash flows remain a 2028/29 story."},"keyFigures":{"customDimensions":{"territory":"EU-27, United Kingdom, Ukraine, Switzerland (all cereals except corn)","first_sales":"end of 2028, farmer use in spring 2029","prior_agreement":"November 2025 Memorandum of Understanding converted to binding agreement","field_trials_2026":"more than 70 joint field trials","addressable_hectares":"9 to 12 million hectares annually (septoria + yellow rust)","protectable_hectares":"more than 1 million hectares of cereals","first_registration_target":"Q3 2028 (core EU), around 2029 (UK and Switzerland)"}},"quotedText":"Signing this binding agreement with Syngenta is a defining milestone for Amoéba","namedEntities":{"people":[{"name":"Matthew Pickard","role":"Syngenta's Head of Seedcare and Biologicals for Europe"},{"name":"Jean-Marc Petat","role":"Managing Director of Green for Agro, Amoéba's biosolutions subsidiary"}],"products":["AXP20","AXPERA","Willaertia magna C2c Maky lysate"],"companies":[{"name":"Amoéba","ticker":"ALMIB","relationship":"filer / technology licensor"},{"name":"Syngenta Crop Protection AG","relationship":"exclusive distribution partner"},{"name":"Syngenta","relationship":"partner (Syngenta Crop Protection parent)"},{"name":"Green for Agro","relationship":"Amoéba's biosolutions subsidiary"}],"dollarAmounts":[{"amount":"€1.5 billion","context":"annual cost to German farmers from septoria yield losses (industry context figure)"}]},"materialImpact":{"score":4,"reasoning":"Amoéba converted its November 2025 MoU with Syngenta Crop Protection into a binding, exclusive long-term supply and distribution agreement covering cereals across the EU-27, UK, Ukraine, and Switzerland — a defining commercial validation for a micro-cap pre-scale biocontrol company. Impact is capped slightly because no financial terms were disclosed and first revenue is not expected until end-2028."},"tickerRelevance":{"others":[],"primary":"ALMIB"},"globalImportance":26,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap (Euronext Growth, France)","eventGravity":"binding exclusive distribution partnership with global ag-leader Syngenta","revenueTimeline":"first sales end-2028, limiting near-term financial impact","partnerBrandBoost":"Syngenta co-branding raises credibility of the announcement","retailFavoriteBoost":0,"financialTermsDisclosed":false}},"event_type":"partnership","event_type_secondary":null,"sentiment":"bullish","material_impact_score":4,"narrative":"Amoéba and Syngenta Crop Protection have signed a binding exclusive supply and distribution agreement for the next-generation biocontrol fungicide AXP20, converting their November 2025 MoU into a long-term commercial and development partnership covering all cereals except corn across the EU-27, UK, Ukraine, and Switzerland.\n\nFirst registrations are targeted for Q3 2028 in core EU markets and around 2029 in the UK and Switzerland, with first sales expected by end of 2028 for farmer use in spring 2029 under a Syngenta trademark.\n\nThe product targets septoria tritici blotch and yellow rust — Europe's most economically damaging cereal diseases, affecting an estimated 9 to 12 million hectares annually — and the partners are running more than 70 joint field trials in 2026, with AXP20 capable of protecting more than 1 million hectares.\n\nAmoéba holds EU approval for the active substance (2025) and a June 2026 French marketing authorization for AXPERA; for the Euronext Growth-listed micro-cap this is a defining commercialization milestone, though no financial terms were disclosed and revenue remains nearly two years out.","key_figures":{"customDimensions":{"territory":"EU-27, United Kingdom, Ukraine, Switzerland (all cereals except corn)","first_sales":"end of 2028, farmer use in spring 2029","prior_agreement":"November 2025 Memorandum of Understanding converted to binding agreement","field_trials_2026":"more than 70 joint field trials","addressable_hectares":"9 to 12 million hectares annually (septoria + yellow rust)","protectable_hectares":"more than 1 million hectares of cereals","first_registration_target":"Q3 2028 (core EU), around 2029 (UK and Switzerland)"}},"named_entities":{"people":[{"name":"Matthew Pickard","role":"Syngenta's Head of Seedcare and Biologicals for Europe"},{"name":"Jean-Marc Petat","role":"Managing Director of Green for Agro, Amoéba's biosolutions subsidiary"}],"products":["AXP20","AXPERA","Willaertia magna C2c Maky lysate"],"companies":[{"name":"Amoéba","ticker":"ALMIB","relationship":"filer / technology licensor"},{"name":"Syngenta Crop Protection AG","relationship":"exclusive distribution partner"},{"name":"Syngenta","relationship":"partner (Syngenta Crop Protection parent)"},{"name":"Green for Agro","relationship":"Amoéba's biosolutions subsidiary"}],"dollarAmounts":[{"amount":"€1.5 billion","context":"annual cost to German farmers from septoria yield losses (industry context figure)"}]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-10T09:34:38.550Z","global_importance":26,"audience_relevance":15,"importance_components":{"tickerTier":"micro-cap (Euronext Growth, France)","eventGravity":"binding exclusive distribution partnership with global ag-leader Syngenta","revenueTimeline":"first sales end-2028, limiting near-term financial impact","partnerBrandBoost":"Syngenta co-branding raises credibility of the announcement","retailFavoriteBoost":0,"financialTermsDisclosed":false}},"durationMs":32901,"modelName":"glm-5.3-flash"}}